Wednesday, April 27, 2016 12:23:18 PM
Bay Area hospitals have treated seven patients who ingested what they thought was the painkiller Norco in recent weeks, according to a report released Tuesday by the U.S. Centers for Disease Control and Prevention. The patients all survived, though at least some experienced nausea, vomiting and difficulty breathing.
The pills were adulterated with fentanyl, the powerful opioid.
Sacramento County health officials have reported 52 Norco-connected poisonings since late March, with 12 of those cases resulting in deaths. Neighboring Yolo County reported another two deaths.
Law enforcement officials investigating the source of the pills will be looking to see whether the Sacramento and Bay Area cases are connected, said Casey Rettig, a Drug Enforcement Administration special agent based in San Francisco. She said she could not discuss details of the DEA's ongoing investigation, but she noted that the Bay Area and Sacramento County illnesses occurred around the same time and that pills in the two areas had the same markings.
"It is our number one priority based out of San Francisco," she said of the investigation. "We definitely want to connect the dots where we can."
Rettig said she was not aware of other cases in California or elsewhere in the country in which fentanyl was sold as Norco.
Norco is a painkiller that contains acetaminophen and hydrocodone. Hydrocodone, also an opioid, is among the most abused prescription drug ingredients in the country.
Fentanyl abuse is also a problem around the country. On the East Coast, dealers have laced heroin with fentanyl and sold fentanyl as heroin, Rettig said. The drug is made in China, sent to Mexico and smuggled across the border, she said.
The pills ingested by the seven Bay Area patients also contained promethazine, said Kathy Vo, a medical toxicology fellow at the University of California, San Francisco who co-authored the CDC study. Promethazine heightens the high that an opioid can provide, Vo said.
Friends and street dealers were among the sources of the pills for the California overdose patients, officials said.
Recent APDN News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/04/2024 10:18:33 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/12/2024 09:25:36 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/12/2024 09:09:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:05:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/08/2024 09:01:31 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/01/2024 09:05:28 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:24:06 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/10/2024 10:16:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:00:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:05:23 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/07/2023 09:01:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 09:05:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 10:09:34 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/07/2023 10:02:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:05:45 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:01:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 08:02:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 09:04:44 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM